Sixth Acquisition Extends Veranex Lead in MedTech Industry Services
Veranex expands global capabilities for human-centered design, innovation, and strategy
2 min read
RALEIGH, N.C.; 9/18/23, 2023 – Veranex, the only global, tech-enabled product development services provider focused on the medical technology industry, announces the newest addition to their executive team in Chief Commerical Officer, Ryan Roberts.
Ryan brings over 30 years of extensive sales and marketing experience,
successfully delivering market-leading growth and margin performance in diverse healthcare segments. His deep understanding of the MedTech landscape is made known through his versatile career, during which he has commercialized products ranging from medical devices, consumables, software, and services.
Most recently Ryan was the Chief Commercial Officer at Sense Biodetection, a venture-backed molecular diagnostics innovator. Prior, he was a Vice President at Edwards Lifesciences’ Critical Care business, CCO at Astute Medical, and V.P. of CareFusion’s (now BD’s) respiratory technologies business.
Veranex’s Chairman & CEO, Pat Donnelly, shared his excitement about the impactful commercial leader joining the team: “All of us here at Veranex could not be more thrilled to have Ryan Roberts join the leadership team.
“All of us here at Veranex could not be more thrilled to have Ryan Roberts join the leadership team. His dynamic approach to the market and knowledge of the industry across all the service lines provided to our clients here at Veranex is a tremendous addition to the company.”
– Pat Donnelly, Veranex CEO and Chairman
His dynamic approach to the market and knowledge of the industry across all the service lines provided to our clients here at Veranex is a tremendous addition to the company.”
Roberts also shared how eager he is to begin this new journey: “Veranex’s portfolio of conceptualization to commercialization services is unparalleled in the market. I’m enthused about the opportunity we have to accelerate market readiness of meaningful, outcomes-changing technologies for our customers and the caregivers and patients they serve.”
As Chief Commercial Officer, Roberts will lead Veranex’s global commercial strategy, refresh organizational sales and marketing philosophies, identify areas of opportunity in emerging markets worldwide. Additionally, he will engage thought leaders at the organization to better capture the one-of-a-kind story of Veranex’s expansive capabilities. His innovative take on commercialization and desire to drive positive change in the industry aligns with Veranex’s mission to tackle healthcare’s biggest challenges and change patient lives across the globe.
About Veranex
Veranex is the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry. Offering expert guidance from concept through to commercialization and across the development continuum, Veranex enables accelerated speed to market, controlled development costs, development risk mitigation, and accelerated market viability assessment. At every stage, Veranex customers realize efficiencies in cost and time while its integrated and comprehensive solutions unify the entire development process.
Press Release: Veranex Acquires Leading Preclinical Services Provider T3 Labs
Raleigh, NC, December 14, 2023—Veranex, provider of the first purpose-built, global service platform for the medtech industry, today announced that...
1 min read
Veranex Acquires Leading Pathology and Histology Provider HORUS Scientific
The addition increases footprint and provides speed, flexibility, and depth of GLP services to North America and the EU. Veranex, the first...